CVS Health Beats Earnings Estimates

Alicia Farmer
November 9, 2018

What is market worth of stock? On 2018/08/27 Hourican Kevin, EVP & President, CVS Pharmacy at CVS, dumped 8,564 shares at an average price of $75 per share.

Separately, it had been reported that some other CVS insiders also took part of the insider trading activity.

Shares of NYSE CVS traded up $4.21 during mid-day trading on Tuesday, reaching $77.90. Royal Bank of Canada reissued a "buy" rating and issued a $90.00 target price on shares of CVS Health in a report on Wednesday, August 8th. CVS Health accounts for approximately 0.7% of Polianta Ltd's portfolio, making the stock its 22nd largest position. Barrow, Hanley, Mewhinney & Strauss is the largest single holder among mutual funds with ownership of over 18.32M CVS shares as of June 30, with a market value of approx. The institutional investor owned 17,800 shares of the pharmacy operator's stock after acquiring an additional 1,000 shares during the quarter.

CVS Health Corporation (CVS) stock has been separated 5.57% away from the 200-day MA.

The CVS Health Corporation has the market capitalization of $76.38B. The true range indicator is the greatest of the following: current high less the current low, the absolute value of the current high less the previous close and the absolute value of the current low less the previous close. The shares were pushed to an intraday high Monday at $74.63. The Stock price down move to its 20 SMA, getting attention form Day Traders as 20-SMA is the last stop on the bus for short-term traders. Company's EPS for the past five years is valued at 11%, leading it to an EPS value of 8.6% for the next five years. Now the market price is up 6.41% on the year and up 1.64% YTD. On the surface, it seems as though the higher/lower the 50-day moving average goes, the more bullish/bearish the market is. The company's stock now has a total float of 1.02B shares. The stock remained 2.78% volatile for the week and 2.67% for the month. On the upside, the share price will test short term resistance at around $74.49. The stock price is settled at $73.69 after trading hours. The failure to get near-term support could push it to $72.38. They issued a "peer perform" rating on the stock. Analysts at Citigroup, shed their negative views on July 09 by lifting it fromNeutral to Buy. Analysts at BofA/Merrill, made their first call about the stock on February 27, recommending it is Buy.

Ariana Grande Almost Falls During First "Thank U, Next" Performance
And for all those who insist everyone lip syncs these kinds of performances, Grande's laughter a couple of times puts that to rest.

Women Help Lead Democrats to US House Majority
And there were other factors at play that helped Democrats keep Republicans off the board for a fifth consecutive election. Now, with a Democratic House breathing down his neck, the world should expect more "fire and fury".

Netflix announce new Irish animated film entitled My Father's Dragon
Bonnie Curtis and Julie Lynn of Mockingbird Pictures produce along with Paul Young of Cartoon Saloon and Tomm Moore. Most recently, we've seen the incredible documentary, entitled The 34th, added to the Netflix roster .

When looking at valuations, CVS Health Corporation (CVS) has a pricey P/E of 50.44x as compared to industry average of 28.16x. The returns on assets of firm also on noticeable level, it has ROA of 2.60%, which signifies how profitable a firm is relative to its total assets.

Start focusing on ordinary profitability ratio which covers margins; CVS has a profit margin of 1.60%. CVS stock price current trend is considered pessimistic. The stock has a debt/capital of 1.83.

CVS Health Corp's quarterly revenue and earnings, reported on Tuesday, topped Wall Street estimates, supported by strong prescription drug sales.

Front end of the store same-store sales rose 0.8 percent versus analysts' expectations of an 0.8 percent drop, despite brick-and-mortar drugstore chains like CVS coming under increasing pressure from consumer shifts to online options. That was better than consensus for $1.61. Both numbers topped analyst expectations of $1.71 and $47.2 billion, respectively.

Excluding items, CVS Health earned $1.73 per share, compared with the average analyst estimate of $1.71.

Other reports by

Discuss This Article